TY  - GEN
AU  - Sadushi-Kolici,Roela
AU  - Jansa,Pavel
AU  - Kopec,Grzegorz
AU  - Torbicki,Adam
AU  - Skoro-Sajer,Nika
AU  - Campean,Ioana-Alexandra
AU  - Halank,Michael
AU  - Simkova,Iveta
AU  - Karlocai,Kristof
AU  - Steringer-Mascherbauer,Regina
AU  - Samarzija,Miroslav
AU  - Salobir,Barbara
AU  - Klepetko,Walter
AU  - Lindner,Jaroslav
AU  - Lang,Irene M
TI  - Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial
SN  - 2213-2619
PY  - 2020///0415
KW  - Antihypertensive Agents
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Monitoring
KW  - methods
KW  - Epoprostenol
KW  - Exercise Tolerance
KW  - drug effects
KW  - Female
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - diagnosis
KW  - Injections, Subcutaneous
KW  - Male
KW  - Middle Aged
KW  - Pulmonary Embolism
KW  - complications
KW  - Severity of Illness Index
KW  - Treatment Outcome
KW  - Walk Test
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S2213-2600(18)30367-9
ER  -